On 22-24 November 2020, PCR London Valves, the world’s largest...

On 22-24 November 2020, PCR London Valves, the world’s largest educational meeting focused on transcatheter therapies for valvular heart disease, took place. This is one of the leading events in this space and is attended by interventional cardiologists, cardiac surgeons, heart teams and industry partners across the globe.We would like to share with you two key presentations that are relevant to Anteris Professor Bernard Prendergast, Consultant Cardiologist at St Thomas’ Hospital, London, Principal Course Director of PCR London Valves and member of the AVR Advisory Board, highlighted the need for a long-term one-stop solution for patients, that can restore the diseased valve back to normal levels. To watch this presentation in full, please click here.Professor Bart Meuris MD, PhD, Chief of Cardiovascular Surgery at the University Hospitals, Leuven, Belgium and Principal Investigator of the company’s first-in-human study presented on Anteris’ behalf, providing an overview of the DurAVR™ heart valve and results generated to date in the first-in-human study. To watch this presentation in full, please click here (the section on Anteris is the second innovation discussed). Please note that accessing this presentation will required to register some details

https://www.pcronline.com/Cases-resources-images/Resources/Educational-interviews/2020/PCR-Valves-e-Course/Better-Hemodynamics-Durability-needed-in-TAVR-to-treat-AS-patients

https://europagroup.6connex.eu/event/pcrcourse/login?shared=true&lang=en-us&return=lobby/n107606/c67079

You might have to copy and paste the link into a browser.